ProjectAspergillosis – Multimodal preclinical imaging of Aspergillus fumigatus invasion and treatment
Basic data
Acronym:
Aspergillosis
Title:
Multimodal preclinical imaging of Aspergillus fumigatus invasion and treatment
Duration:
01/05/2023 to 30/04/2026
Abstract / short description:
Aspergillus fumigatus (A. fumigatus) is a ubiquitous mold, whose airborne spores are frequently
inhaled. While immunocompetent people do not suffer from a related infection, people with a
compromised immune system frequently develop an invasive infection from the lungs resulting from inhalation of A.
fumigatus, termed invasive Aspergillosis (IA). To address this clinical need, the use of targeted contrast agents for molecular imaging
techniques such as Positron Emission Tomography (PET) or Single Photon Emission
Tomography (SPECT) could provide an efficient solution.
inhaled. While immunocompetent people do not suffer from a related infection, people with a
compromised immune system frequently develop an invasive infection from the lungs resulting from inhalation of A.
fumigatus, termed invasive Aspergillosis (IA). To address this clinical need, the use of targeted contrast agents for molecular imaging
techniques such as Positron Emission Tomography (PET) or Single Photon Emission
Tomography (SPECT) could provide an efficient solution.
Involved staff
Managers
Faculty of Medicine
University of Tübingen
University of Tübingen
Local organizational units
Department of Preclinical Imaging and Radiopharmacy
Department of Radiology
Hospitals and clinical institutes, Faculty of Medicine
Hospitals and clinical institutes, Faculty of Medicine
Funders
Bonn, Nordrhein-Westfalen, Germany